HHMI Spends $30 Million On Undergrads

WASHINGTON—Taking its cue from recent studies that point to a funding gap in science education at liberal arts colleges, the Howard Hughes Medical Institute (HHMI) has begun a program to upgrade science curricula at selected undergraduate institutions. HHMI has invited 76 liberal arts colleges not affiliated with any Ph.D.-granting university and 18 historically black colleges to compete for the grants, which will range from $500,000 to $2 million. The winners will be announced next sp

Written byRon Cowen
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WASHINGTON—Taking its cue from recent studies that point to a funding gap in science education at liberal arts colleges, the Howard Hughes Medical Institute (HHMI) has begun a program to upgrade science curricula at selected undergraduate institutions.

HHMI has invited 76 liberal arts colleges not affiliated with any Ph.D.-granting university and 18 historically black colleges to compete for the grants, which will range from $500,000 to $2 million. The winners will be announced next spring, according to Joseph Perpich, HHMI vice president for grants and special programs.

HHMI expects to spend $30 million in the first year of a three-year effort, Perpich said. The program may be expanded in subsequent years to include undergraduate programs at major research universities.

“The liberal arts colleges have had little government support,” said Perpich, “and have campaigned to increase their science research faculty based on the fact that a large percentage of their students ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies